EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY – Get Free Report) was the recipient of a large decline in short interest in February. As of February 13th, there was short interest totaling 11,183 shares, a decline of 81.4% from the January 29th total of 60,082 shares. Currently, 0.0% of the company’s stock are sold short. Based on an average daily trading volume, of 171,058 shares, the days-to-cover ratio is presently 0.1 days. Based on an average daily trading volume, of 171,058 shares, the days-to-cover ratio is presently 0.1 days. Currently, 0.0% of the company’s stock are sold short.
Analysts Set New Price Targets
A number of brokerages recently issued reports on ESLOY. Royal Bank Of Canada restated an “outperform” rating on shares of EssilorLuxottica in a research note on Tuesday, October 28th. Kepler Capital Markets raised EssilorLuxottica from a “hold” rating to a “buy” rating in a report on Thursday, January 15th. Zacks Research cut EssilorLuxottica from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, November 18th. UBS Group upgraded EssilorLuxottica from a “hold” rating to a “strong-buy” rating in a research report on Thursday, November 27th. Finally, The Goldman Sachs Group reissued a “buy” rating on shares of EssilorLuxottica in a research report on Friday, December 5th. Two equities research analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Buy”.
Check Out Our Latest Report on EssilorLuxottica
EssilorLuxottica Stock Performance
About EssilorLuxottica
EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.
The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.
Featured Articles
- Five stocks we like better than EssilorLuxottica
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- This makes me furious
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for EssilorLuxottica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EssilorLuxottica and related companies with MarketBeat.com's FREE daily email newsletter.
